{
  "$schema": "folio-library-entry/v1",
  "id": "10665-340255",
  "blocks": [
    {
      "id": "library/10665-340255/blocks/prose-sec-front-matter",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Front matter",
      "pageStart": 1,
      "pageEnd": 5,
      "target": "../sections/sec-front-matter.md",
      "narrative": null,
      "content": "Module 2: Screening\nSystematic screening for \ntuberculosis disease\nWHO \nconsolidated \nguidelines on\ntuberculosis\nSystematic screening for \ntuberculosis disease\nModule 2: Screening\nWHO \nconsolidated \nguidelines on\ntuberculosis\nWHO consolidated guidelines on tuberculosis. Module 2: screening – systematic screening for tuberculosis disease\nISBN 978–92–4-002267–6 (electronic version)\nISBN 978–92–4-002268–3 (print version)\n© World Health Organization 2021\nSome rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence \n(CC BY-NC-SA 3.0 IG",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The cover, title and copyright pages of the 2021 WHO consolidated guidelines on tuberculosis, Module 2: systematic screening for TB disease, with ISBNs, Creative Commons licence terms, suggested citation and disclaimers.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Contents",
      "pageStart": 5,
      "pageEnd": 7,
      "target": "../sections/sec-000-contents.md",
      "narrative": null,
      "content": "Acknowledgements\b\nv\nAbbreviations and acronyms\b\nviii\nDefinitions\b\nix\nExecutive summary\b\n1\n1. Introduction\b\n5\n1.1\t Background\b\n5\n1.2\t Definition and objectives of systematic screening for TB disease\b\n5\n1.3\t Scope of the 2021 update\b\n6\n1.4\t Rationale for the guideline update\b\n8\n1.5\t Objectives of the guideline update\b\n8\n1.6\t Target audience\b\n9\n2. Recommendations for systematic screening for TB disease in targeted \npopulations\b\n11\n2.1\t Systematic screening for TB disease in the general population \b\n13\n2.2\t Systematic screening for TB disease among people with structural risk factors for TB\b\n15\n2.",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The table of contents, listing chapters on recommendations for target populations, screening tools, monitoring and evaluation and research gaps, plus links to three web annexes on methods and GRADE evidence tables.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Acknowledgements",
      "pageStart": 7,
      "pageEnd": 10,
      "target": "../sections/sec-001-acknowledgements.md",
      "narrative": null,
      "content": "Acknowledgements\nThe production of the WHO consolidated guidelines on tuberculosis. Module 2: screening was coordinated \nand written by Cecily Miller, with support from Annabel Baddeley, Dennis Falzon and Matteo Zignol, \nunder the overall direction of Tereza Kasaeva, Director of the World Health Organization (WHO) \nGlobal Tuberculosis Programme. The WHO Global Tuberculosis Programme gratefully acknowledges \nthe contribution of all experts involved in producing these guidelines1. This update was funded \nby grants provided to WHO by the United States Agency for International Development and the",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Credits the WHO Global Tuberculosis Programme staff who coordinated and wrote the TB screening guidelines and names the funders. It lists members of the Guideline Development Group, the external review group, evidence reviewers and others who contributed.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Abbreviations and acronyms",
      "pageStart": 10,
      "pageEnd": 11,
      "target": "../sections/sec-002-abbreviations-and-acronyms.md",
      "narrative": null,
      "content": "ART\t\nantiretroviral treatment\nCAD\t\ncomputer-aided detection of TB-related abnormalities on chest radiography\nCI\t\nconfidence interval\nCRP\t\nC-reactive protein\nCXR\t\nchest radiograph (chest X-ray)\nERG \t\nExternal Review Group\nGDG \t\nGuideline Development Group\nGRADE\t\nGrading of Recommendations Assessment, Development and Evaluation\nIPD\t\nindividual patient data\nLF-LAM\t\nlateral flow urine lipoarabinomannan assay\nmWRD\t\nmolecular WHO-recommended rapid diagnostic test\nNNS\t\nnumber needed to screen (to detect one person with tuberculosis disease)\nPICO\t\npopulation, intervention, comparator and outcomes (fra",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists the abbreviations and acronyms used in the TB screening guidelines, such as CAD, CXR, mWRD, NNS and W4SS.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Definitions",
      "pageStart": 11,
      "pageEnd": 13,
      "target": "../sections/sec-003-definitions.md",
      "narrative": null,
      "content": "Definitions\nThe definitions below apply to terms as used in these guidelines, and they may have different \nmeanings elsewhere.\nActive (tuberculosis) case-finding (ACF): Provider-initiated screening and testing in communities \nby mobile teams, often using mobile X-ray and rapid molecular tests. The term is sometimes used \nsynonymously with “systematic screening”.\nComputer-aided detection (CAD): The use of specialized software to interpret abnormalities on \nchest radiographs that are suggestive of TB. The results are expressed as abnormality scores. CAD \nmay be used for screening or triage.\nEnha",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines the key terms used in the TB screening guidelines, including active, enhanced and passive case-finding, computer-aided detection, number needed to screen and repeat screening. It also explains initial screening, triage and the meaning of TB disease as distinct from TB infection.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Executive summary",
      "pageStart": 13,
      "pageEnd": 17,
      "target": "../sections/sec-004-executive-summary.md",
      "narrative": null,
      "content": "Executive summary\nTuberculosis (TB) is a leading cause of death from a single infectious agent, despite being largely \ncurable and preventable. In 2019 an estimated 2.9 million of the 10 million people who fell ill with TB \nwere not diagnosed or reported to the World Health Organization (WHO). The Political Declaration \nadopted by the United Nations General Assembly in September 2018 at the High-Level Meeting on \nthe Fight Against Tuberculosis commits to, among other goals, diagnosing and treating 40 million \npeople with TB by 2022. In order to achieve this ambitious target, there is an urgent",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Summarizes why WHO updated its 2013 guidance on systematic TB screening, citing the 2.9 million people with TB who went undiagnosed or unreported in 2019 and global targets for diagnosis. It explains that a Guideline Development Group reviewed new evidence in 2020, including on computer-aided detection of chest X-rays, C-reactive protein and rapid molecular tests. The summary presents the recommendations on which populations to screen and which tools to use, ending with a box on the main changes from the earlier guidance.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/table-001",
      "types": [
        "folio-assistant-core:Table",
        "doco:Table"
      ],
      "kind": "table",
      "title": "Table 1. Recommendations in the WHO consolidated guidelines on tuberculosis. Module 2: screening – systematic screening for tuberculosis disease, 2021",
      "pageStart": 14,
      "pageEnd": 16,
      "target": "../tables/table-1.csv",
      "narrative": "draft",
      "content": "The table lists the 17 recommendations of the 2021 WHO guidelines on systematic screening for TB disease, grouped into screening in targeted populations (1–8) and tools for screening (9–17). Each recommendation is followed by its status (new, updated or existing), its strength and the certainty of the evidence.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Introduction",
      "pageStart": 17,
      "pageEnd": 17,
      "target": "../sections/sec-005-1-introduction.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Background",
      "pageStart": 17,
      "pageEnd": 17,
      "target": "../sections/sec-006-11-background.md",
      "narrative": null,
      "content": "Tuberculosis (TB) is a leading cause of death from a single infectious agent, despite being largely \ncurable and preventable. In 2019, an estimated 2.9 million of the 10 million people who fell ill with TB \nwere not diagnosed or reported to the World Health Organization (WHO) (1). WHO’s End TB Strategy \nenvisions a 90% reduction in TB incidence and a 95% reduction in TB deaths by 2035 (2, 3), and the \nDeclaration adopted by the United Nations General Assembly in September 2018 at the High-Level \nMeeting on the Fight Against Tuberculosis commits to diagnosing and treating 40 million people \nwit",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives the background to the update, noting the gap in TB diagnosis, the End TB Strategy and UN targets, and the new evidence on screening since WHO's 2013 guidelines.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Definition and objectives of systematic screening for TB disease",
      "pageStart": 17,
      "pageEnd": 18,
      "target": "../sections/sec-007-12-definition-and-objectives-of-systematic-scree.md",
      "narrative": null,
      "content": "for TB disease\nFor the purpose of this guideline, systematic screening for TB disease is defined as the systematic \nidentification of people at risk for TB disease, in a predetermined target group, by assessing \nsymptoms and using tests, examinations or other procedures that can be applied rapidly. \nThe screening tests, examinations and other procedures should efficiently distinguish people with a \nhigh probability of having TB disease from those who are unlikely to have TB disease. Among those \nwhose screening is positive, the diagnosis needs to be established by diagnostic evaluation, consis",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines systematic screening for TB disease as provider-initiated identification of people at risk in a target group using rapid tests, followed by diagnostic confirmation. It sets out the two aims of screening: early detection and treatment for individuals, and reduced transmission and incidence in the population.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Scope of the 2021 update",
      "pageStart": 18,
      "pageEnd": 20,
      "target": "../sections/sec-008-13-scope-of-the-2021-update.md",
      "narrative": null,
      "content": "Fig. 1 summarizes the potential contribution of TB screening to standard TB care practices based on \nthe above frameworks for TB screening and shows the conceptual framework that guided the 2021 \nupdate to the TB screening guidelines.\nFig. 1. Conceptual framework for the 2021 WHO update to guidelines for systematic \nscreening for TB. Numbers in parentheses refer to the PICO (population, intervention, \ncomparator and outcome) questions that guided the evidence gathering\nACTIVITIES\nScreening \ninterventions \nand activities \n(including a range \nof health centre-, \ncommunity- and \nhousehold-based",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Presents the conceptual framework for the 2021 update, linking screening inputs and activities to individual and population outcomes such as earlier diagnosis, better treatment results and reduced transmission. It then lists the PICO and background questions used to gather evidence, covering effectiveness, screening tool accuracy, numbers needed to screen, risk factors, costs and community attitudes.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/figure-vfig-p019",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 19,
      "pageEnd": 19,
      "target": "../figures/vfig-p019.webp",
      "narrative": "draft",
      "content": "Fig. 1, a conceptual framework (logic model) for systematic screening for TB, in four columns: Inputs (political and stakeholder engagement, financial resources, human resources, equipment and supplies) feed Activities (screening interventions and activities, including health centre-, community- and household-based activities). These lead to individual-level outcomes (increased TB knowledge, awareness and care-seeking; increased diagnosis and treatment initiation; reduced diagnostic delay; improved treatment outcomes; reduced costs and adverse social consequences) and population-level outcomes (reduced time of infectiousness and prevalence of infectious cases, reduced transmission, and reduced incidence and prevalence of TB).",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Rationale for the guideline update",
      "pageStart": 20,
      "pageEnd": 20,
      "target": "../sections/sec-009-14-rationale-for-the-guideline-update.md",
      "narrative": null,
      "content": "Since the publication of the first WHO guidelines on systematic screening for TB in 2013 (5), there \nhave been numerous studies, including reviews, randomized controlled trials, observational studies, \nmodelling and cost–effectiveness research, evaluating the real or potential impacts of screening \ninterventions on both individual-level and community-level outcomes related to TB. There have also \nbeen numerous prevalence surveys since 2013, which have shed new light on the magnitude of the \nburden of TB in several key countries. The majority of prevalence surveys have shown that the burden \nof",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that the update was prompted by many new studies on screening impact and by prevalence surveys showing a larger TB burden than previously thought.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Objectives of guideline update",
      "pageStart": 20,
      "pageEnd": 21,
      "target": "../sections/sec-010-15-objectives-of-guideline-update.md",
      "narrative": null,
      "content": "The specific objectives of the guideline update are:\n1.\t to support Member States in implementing effective TB screening interventions by providing \nupdated information about the expected impact of TB screening on patient-important outcomes \nand the epidemiology of TB, the expected yield of screening interventions and the expected \nperformance of different screening tools and algorithms;\n2.\t to contribute to finding more people with TB and finding them earlier in the course of disease \nin order to reduce disease burden, morbidity and mortality, and costs and financial hardship for \npeople suff",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States the objectives of the update: to help countries implement effective screening with current evidence on impact, yield and tool performance, and to find more people with TB earlier.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-011",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Target audience",
      "pageStart": 21,
      "pageEnd": 23,
      "target": "../sections/sec-011-16-target-audience.md",
      "narrative": null,
      "content": "This guideline is intended for personnel working in national TB programmes, national HIV/AIDS \nprogrammes or their equivalents, and other relevant national health programmes in ministries \nof health; other relevant ministries working in public health and screening; and for other health \npolicymakers, clinicians and public health practitioners working on TB, HIV and infectious diseases in \nthe public and private sectors. The recommendations provided here must be adapted to local settings. \nAn accompanying operational handbook, WHO operational handbook on tuberculosis. Module 2: \nscreening – sys",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Identifies the intended readers of the guideline, such as national TB and HIV programme staff, policymakers and clinicians, and points to an accompanying operational handbook for adapting the recommendations locally.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-012",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Recommendations for systematic screening for TB disease in targeted populations",
      "pageStart": 23,
      "pageEnd": 25,
      "target": "../sections/sec-012-2-recommendations-for-systematic-screening-for-t.md",
      "narrative": null,
      "content": "systematic screening for TB \ndisease in targeted populations\nIn this guideline, recommendations about systematic screening for TB disease are made for distinct \npopulations for whom it is judged that the benefits and desirable effects of screening outweigh the \npotential harms. \nSystematic screening for TB disease can be done for an entire population (community-wide screening) \nor it can be targeted at selected risk groups or subpopulations of people who may be at higher risk of \nbeing exposed to TB, developing TB disease or suffering poor outcomes from the disease, or some \ncombination of the",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces the population-specific recommendations, explaining that screening may cover whole communities or be targeted at higher-risk groups and how strong and conditional recommendations are distinguished. It sets out the recommendation on screening the general population in high-prevalence settings. The evidence reviewed includes trials and studies in which community-wide screening reduced TB prevalence or infection among children.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-013",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Systematic screening for TB disease in the general population",
      "pageStart": 25,
      "pageEnd": 27,
      "target": "../sections/sec-013-21-systematic-screening-for-tb-disease-in-the-ge.md",
      "narrative": null,
      "content": "population was recommended in defined populations with extremely high levels of undetected TB, \ndefined as a 1% prevalence or higher. Based on the updated evidence reviewed, the GDG concluded \nthat the threshold of 1% recommended in the 2013 guidelines could be lowered, but considered \nthat screening under programmatic conditions would not perform as well as was observed in the \ntrial in Viet Nam and, therefore, proposed a 0.5% threshold to guide country implementation. Thus, \nthe GDG recommended that general population screening may be considered in defined areas \nwith a prevalence of undetec",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains why the prevalence threshold for general population screening was lowered from 1% to 0.5% undetected TB, and discusses implementation factors such as prevalence, coverage and the sensitivity of screening algorithms. It also covers possible harms and concerns of people being screened, such as stigma and confidentiality.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-014",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Systematic screening for TB disease among people with structural risk factors for TB",
      "pageStart": 27,
      "pageEnd": 28,
      "target": "../sections/sec-014-22-systematic-screening-for-tb-disease-among-peo.md",
      "narrative": null,
      "content": "people with structural risk factors for TB\n2. Systematic screening for TB disease may be conducted among subpopulations with structural \nrisk factors for TB. These include urban poor communities, homeless communities, communities \nin remote or isolated areas, indigenous populations, migrants, refugees, internally displaced \npersons and other vulnerable or marginalized groups with limited access to health care \n(existing recommendation: conditional recommendation, very low certainty of evidence).\n2.2.1 Summary of evidence and rationale\nPopulations with structural risk factors for TB are those t",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives the conditional recommendation to screen groups with structural risk factors, such as urban poor, homeless, remote, indigenous, migrant and displaced populations, and explains these risk factors. It notes that no new evidence was found since 2013 and offers implementation advice, including combining TB screening with other health activities.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-015",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Systematic screening for TB disease among people living with HIV",
      "pageStart": 28,
      "pageEnd": 28,
      "target": "../sections/sec-015-23-systematic-screening-for-tb-disease-among-peo.md",
      "narrative": null,
      "content": "people living with HIV\n3. People living with HIV should be systematically screened for TB disease at each visit to a \nhealth facility \n(existing recommendation: strong recommendation, very low certainty of evidence).\n2.3.1 Summary of evidence and rationale\nPeople living with HIV are approximately 19 times more likely to develop TB disease than those without \nHIV; in 2019, an estimated 44% of people living with HIV who also had TB disease did not reach care, \nand 30% of all HIV-related deaths were due to TB (1). Thus, ensuring early detection and treatment \nfor TB among all people living with H",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out the strong recommendation that people living with HIV be screened for TB at every health facility visit, citing their much higher TB risk, and describes follow-up diagnostic testing and preventive treatment.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-016",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Systematic screening for TB disease among household and other close contacts of individuals with TB disease",
      "pageStart": 28,
      "pageEnd": 30,
      "target": "../sections/sec-016-24-systematic-screening-for-tb-disease-among-hou.md",
      "narrative": null,
      "content": "household and other close contacts of individuals \nwith TB disease \n4. Household contacts and other close contacts of individuals with TB disease should be \nsystematically screened for TB disease \n(updated recommendation: strong recommendation, moderate certainty of evidence).\n2.4.1 Summary of evidence and rationale\nHousehold and close contacts of individuals with TB disease are at high risk of TB infection and \ndeveloping TB disease. A systematic review conducted for the guideline update found the weighted \npooled prevalence of TB disease among all close contacts of TB patients was 3.6% (95%",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives the updated strong recommendation to screen household and close contacts of people with TB, citing a pooled disease prevalence of 3.6% and trials in Viet Nam, South Africa and Zambia showing benefits. It then covers implementation, including prioritizing contacts and offering HIV testing and preventive treatment where appropriate.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-017",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Systematic screening for TB disease in prisons and other penitentiary institutions",
      "pageStart": 30,
      "pageEnd": 31,
      "target": "../sections/sec-017-25-systematic-screening-for-tb-disease-in-prison.md",
      "narrative": null,
      "content": "and other penitentiary institutions\n5. Systematic screening for TB disease should be conducted in prisons and penitentiary \ninstitutions \n(updated recommendation: strong recommendation, very low certainty of evidence).\n2.5.1 Summary of evidence and rationale\nPeople in prisons and other penitentiary institutions are at an increased risk for TB compared with \nthe general population, and they often have limited access to health care services. The estimated \nincidence of TB among people residing in prisons is 23 times higher than that among the general \npopulation (24). Data reviewed for the GDG m",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Presents the updated strong recommendation for TB screening in prisons, citing a much higher TB incidence among prisoners and studies showing earlier and increased case detection. Implementation advice covers screening at entry and periodically, infection control and access to diagnosis.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-018",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Systematic screening for TB disease among miners and others exposed to silica dust",
      "pageStart": 31,
      "pageEnd": 31,
      "target": "../sections/sec-018-26-systematic-screening-for-tb-disease-among-min.md",
      "narrative": null,
      "content": "miners and others exposed to silica dust \n6. Current and former workers in workplaces with silica exposure should be systematically \nscreened for TB disease \n(existing recommendation: strong recommendation, low certainty of evidence).\n2.6.1 Summary of evidence and rationale\nExposure to silica dust and silicosis are among the strongest risk factors for TB, with a relative risk of \n2.8–39 for silicosis, depending on the severity of the disease (30). Silicosis is common in miners (31, 32), \nwhich is a primary reason for the high incidence of TB among them, and this is often compounded \nby a high",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out the strong recommendation to screen current and former workers exposed to silica dust, given the high TB risk linked to silicosis, and advises screening at least every 12 months, ideally combined with improvements to working conditions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-019",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Systematic screening for TB disease among people attending health care services who have clinical risk factors for TB",
      "pageStart": 31,
      "pageEnd": 35,
      "target": "../sections/sec-019-27-systematic-screening-for-tb-disease-among-peo.md",
      "narrative": null,
      "content": "people attending health care services who have \nclinical risk factors for TB\n7. In settings where the TB prevalence in the general population is 100/100 000 population or \nhigher, systematic screening for TB disease may be conducted among people with a risk factor \nfor TB who are either seeking health care or who are already in care \n(existing recommendation: conditional recommendation, very low certainty of evidence).\n8. People with an untreated fibrotic lesion seen on chest X-ray may be systematically screened \nfor TB disease \n(existing recommendation: conditional recommendation, very low ce",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives conditional recommendations to screen people with clinical TB risk factors in health care settings where prevalence is at least 100 per 100,000, and people with untreated fibrotic lesions on chest X-ray. It reviews evidence on risk factors such as HIV, diabetes, malnutrition, smoking and alcohol use, summarized in a table. Implementation points include prioritizing groups according to local epidemiology, offering preventive treatment where appropriate and considering screening of health care workers.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/table-002",
      "types": [
        "folio-assistant-core:Table",
        "doco:Table"
      ],
      "kind": "table",
      "title": "Table 2. Risk factors for tuberculosis (TB) to be considered when prioritizing TB screening among people attending for health care",
      "pageStart": 32,
      "pageEnd": 33,
      "target": "../tables/table-2.csv",
      "narrative": "draft",
      "content": "The table lists 11 clinical and other risk factors to consider when prioritizing TB screening among people attending health care, such as fibrotic lesions on chest X-ray, diabetes, previous TB, smoking, alcohol use disorder and pregnancy. For each it summarizes the evidence on the risk of TB or of poor TB outcomes, with references in footnotes.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-020",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Recommendations for tools for systematic screening for TB disease",
      "pageStart": 35,
      "pageEnd": 35,
      "target": "../sections/sec-020-3-recommendations-for-tools-for-systematic-scree.md",
      "narrative": null,
      "content": "for systematic screening for TB \ndisease\nTB screening tools are designed to distinguish people with a higher probability of having TB disease \nfrom those with a low probability and can be assumed to be free of TB disease. They are not intended \nto provide a definitive diagnosis. In general, they need to be able to be implemented easily and relay \nresults rapidly in order to be informative in a screening context. Screening tests need to be followed \nby a diagnostic test, offered as part of a comprehensive clinical evaluation, to confirm or rule out TB \ndisease in individuals who screen positive",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces the recommendations on screening tools, explaining that tools separate people likely to have TB from those unlikely to have it and must be followed by diagnostic tests, and cites WHO target accuracy benchmarks.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-021",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Tools for screening for TB disease among the general population and high-risk groups",
      "pageStart": 35,
      "pageEnd": 37,
      "target": "../sections/sec-021-31-tools-for-screening-for-tb-disease-among-the.md",
      "narrative": null,
      "content": "general population and high-risk groups \n9. Among individuals aged 15 years and older in populations in which TB screening is \nrecommended, systematic screening for TB disease may be conducted using a symptom screen, \nchest X-ray or molecular WHO-recommended rapid diagnostic tests, alone or in combination \n(new recommendation: conditional recommendation, very low certainty of evidence for \ntest accuracy).\n3.1.1 Summary of the evidence and rationale\nThe data used to inform this recommendation came from a systematic review of the diagnostic \naccuracy of using symptoms and chest radiography to de",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Recommends that people aged 15 and over in groups eligible for screening may be screened with symptom questions, chest X-ray or rapid molecular tests, alone or combined. It summarizes systematic review evidence on the accuracy of each tool, with a table of sensitivity and specificity. The section closes by advising countries to fit these tools into national algorithms according to goals, resources and equity.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/table-003",
      "types": [
        "folio-assistant-core:Table",
        "doco:Table"
      ],
      "kind": "table",
      "title": "Table 3. Diagnostic accuracy of symptoms, chest radiography, and molecular WHO-recommended rapid diagnostic tests for screening for TB disease",
      "pageStart": 36,
      "pageEnd": 36,
      "target": "../tables/table-3.csv",
      "narrative": "draft",
      "content": "The table compares the pooled sensitivity and specificity of screening tests for TB disease – cough of different durations, any TB symptom, chest radiography and molecular WHO-recommended rapid diagnostic tests – against the WHO target product profile, with the number of studies and participants behind each estimate.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-022",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Use of computer-aided detection software for automated reading of digital chest radiographs",
      "pageStart": 37,
      "pageEnd": 40,
      "target": "../sections/sec-022-32-use-of-computer-aided-detection-software-for.md",
      "narrative": null,
      "content": "automated reading of digital chest radiographs\n10. Among individuals aged 15 years and older in populations in which TB screening is \nrecommended, computer-aided detection software programmes may be used in place of \nhuman readers for interpreting digital chest X-rays for screening and triage for TB disease \n(new recommendation: conditional recommendation, low certainty of evidence).\n3.2.1 Summary of the evidence and rationale\nThe use of CXR to screen for TB is a practice that goes back several decades. CXRs are also routinely \nused for triage of patients presenting to care who are displaying",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Presents a new conditional recommendation that computer-aided detection software may replace human readers in interpreting digital chest X-rays for TB screening and triage in people aged 15 and over. It explains that chest radiography is limited by shortages of trained readers and variability between readers, and that many software packages now estimate the likelihood of TB. It ends with implementation needs such as digital radiography equipment, stable internet and maintenance, noting that costs depend on the setting.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/table-004",
      "types": [
        "folio-assistant-core:Table",
        "doco:Table"
      ],
      "kind": "table",
      "title": "Table 4. Sensitivity and specificity ranges of computer-aided detection software and human readers interpreting digital chest radiographs for detection of bacteriologically confirmed TB across three software programmes, from three independent evaluations of the software in a range of populations and settings",
      "pageStart": 39,
      "pageEnd": 39,
      "target": "../tables/table-4.csv",
      "narrative": "draft",
      "content": "The table gives the ranges of sensitivity and specificity of computer-aided detection (CAD) software and of human readers interpreting digital chest X-rays for bacteriologically confirmed TB, separately for the screening and triage use cases, alongside the WHO target product profile.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-023",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Tools for screening for TB disease among people living with HIV",
      "pageStart": 40,
      "pageEnd": 47,
      "target": "../sections/sec-023-33-tools-for-screening-for-tb-disease-among-peop.md",
      "narrative": null,
      "content": "living with HIV\n11. Among adults and adolescents living with HIV, systematic screening for TB disease should \nbe conducted using the WHO-recommended four symptom screen and those who report any \none of the symptoms of current cough, fever, weight loss or night sweats may have TB and \nshould be evaluated for TB and other diseases \n(existing recommendation: strong recommendation, moderate certainty of evidence).\n12. Among adults and adolescents living with HIV, C-reactive protein with a cut-off of > 5 mg/L \nmay be used to screen for TB disease \n(new recommendation: conditional recommendation, lo",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out recommendations on tools for TB screening among adults and adolescents living with HIV, keeping the four-symptom screen and adding C-reactive protein above 5 mg/L, chest X-ray and molecular rapid tests as options. It also strongly recommends systematic molecular testing of HIV inpatients in medical wards where TB prevalence exceeds 10%. The section summarises the evidence on the accuracy of these tools, as the start and end of this cut block show. It ends by encouraging countries to monitor screening yield among people with HIV by screening tool.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/table-005",
      "types": [
        "folio-assistant-core:Table",
        "doco:Table"
      ],
      "kind": "table",
      "title": "Table 5. Diagnostic accuracy of the WHO-recommended four-symptom screen among different subpopulations of people living with HIV compared with culture as a reference standard",
      "pageStart": 42,
      "pageEnd": 42,
      "target": "../tables/table-5.csv",
      "narrative": "draft",
      "content": "The table gives the sensitivity and specificity (95% CI) of the WHO-recommended four-symptom screen (W4SS), compared with culture, for TB among people living with HIV overall and in subpopulations (inpatients, outpatients on and not on ART, CD4 ≤ 200 cells/µL, pregnant women), with the number of studies and participants, against the WHO target product profile.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-340255/blocks/table-006",
      "types": [
        "folio-assistant-core:Table",
        "doco:Table"
      ],
      "kind": "table",
      "title": "Table 6. Diagnostic accuracy of C-reactive protein using a cut-off > 5 mg/L among different subpopulations of people living with HIV compared with culture as a reference standard",
      "pageStart": 43,
      "pageEnd": 43,
      "target": "../tables/table-6.csv",
      "narrative": "draft",
      "content": "The table gives the sensitivity and specificity (95% CI) of C-reactive protein at a cut-off of > 5 mg/L, compared with culture, for TB among people living with HIV overall and in subpopulations (inpatients, outpatients on and not on ART, CD4 ≤ 200 cells/µL, pregnant women), with the number of studies and participants, against the WHO target product profile.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-340255/blocks/table-007",
      "types": [
        "folio-assistant-core:Table",
        "doco:Table"
      ],
      "kind": "table",
      "title": "Table 7. Diagnostic accuracy among different subpopulations of people living with HIV of the WHO-recommended four-symptom screen combined with chest X-ray (any abnormality) compared with culture as the reference standard and using a positive or abnormal result on either screen or both",
      "pageStart": 44,
      "pageEnd": 44,
      "target": "../tables/table-7.csv",
      "narrative": "draft",
      "content": "The table gives the sensitivity and specificity (95% CI) of the WHO-recommended four-symptom screen combined in parallel with chest X-ray (any abnormality), compared with culture, for TB among people living with HIV overall and in subpopulations (inpatients, outpatients on and not on ART, CD4 ≤ 200 cells/µL, pregnant women), with the number of studies and participants, against the WHO target product profile.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-340255/blocks/table-008",
      "types": [
        "folio-assistant-core:Table",
        "doco:Table"
      ],
      "kind": "table",
      "title": "Table 8. Diagnostic accuracy of molecular WHO-recommended rapid diagnostic tests for screening for TB among different subpopulations of people living with HIV compared with culture as a reference standard",
      "pageStart": 45,
      "pageEnd": 45,
      "target": "../tables/table-8.csv",
      "narrative": "draft",
      "content": "The table gives the sensitivity and specificity (95% CI) of molecular WHO-recommended rapid diagnostic tests used for screening, compared with culture, for TB among people living with HIV overall and in subpopulations (inpatients, outpatients on and not on ART, CD4 ≤ 200 cells/µL, pregnant women), with the number of studies and participants, against the WHO target product profile.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-024",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Tools for systematic screening for TB disease among children and adolescents",
      "pageStart": 47,
      "pageEnd": 49,
      "target": "../sections/sec-024-34-tools-for-systematic-screening-for-tb-disease.md",
      "narrative": null,
      "content": "among children and adolescents \n16. Among individuals younger than 15 years who are close contacts of someone with TB, \nsystematic screening for TB disease should be conducted using a symptom screen including \nany one of cough, fever or poor weight gain; or chest radiography; or both \n(new recommendation: strong recommendation, moderate to low certainty of evidence for test \naccuracy). \n17. Among children younger than 10 years who are living with HIV, systematic screening for \nTB disease should be conducted using a symptom screen including any one of current cough, \nfever, poor weight gain or",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives recommendations for screening children and adolescents, using symptoms, chest radiography or both for close contacts under 15, and a symptom screen including contact history for children under 10 with HIV. It notes that children accounted for about 12% of TB cases but 16% of deaths in 2019, showing the need for better case detection. It advises placing these tools within national screening and diagnostic algorithms described in the operational handbook.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-025",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Monitoring and evaluation",
      "pageStart": 49,
      "pageEnd": 49,
      "target": "../sections/sec-025-4-monitoring-and-evaluation.md",
      "narrative": null,
      "content": "4. Monitoring and evaluation\nIn this section, we consider the monitoring and evaluation required to support the implementation of \nTB screening programmes. The operational handbook contains more details about the monitoring, \nsurveillance and evaluation of TB screening interventions (7).\nWhen considering implementing screening in the general population, it is important to know the \nepidemiology of TB and the prevalence of undetected TB in the community. This will help to estimate \nthe impact of any screening programme. TB disease prevalence surveys are used to assess the \nbaseline occurrence o",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that planning TB screening requires knowing local TB epidemiology, using prevalence surveys or notification data alongside risk factors. It advises monitoring in high-burden settings such as prisons and allows screening to stop when the burden stays low, with surveillance continuing.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-026",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Indicators",
      "pageStart": 49,
      "pageEnd": 50,
      "target": "../sections/sec-026-41-indicators.md",
      "narrative": null,
      "content": "Continued monitoring can help programme managers assess the performance of the TB screening \ncomponents that are within their purview. The following indicators should be considered for each \ntargeted risk group:\n1.\t the number of people eligible for screening;\n2.\t the number of people screened (considering the first screening and second screening separately, \nif applicable);\n3.\t the proportion of those eligible for screening who were screened;\n4.\t the number of people with presumptive TB who were identified;\n5.\t the number of people undergoing diagnostic investigation;\n6.\t the number of people",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists indicators for monitoring TB screening in each risk group, from numbers eligible and screened to diagnoses, number needed to screen, initial defaulters and treatment outcomes. It notes the value of disaggregation and the difficulty of estimating eligible populations in community outreach.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-027",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Routines for recording and reporting",
      "pageStart": 50,
      "pageEnd": 50,
      "target": "../sections/sec-027-42-routines-for-recording-and-reporting.md",
      "narrative": null,
      "content": "In order to obtain the required information for the indicators described above, a TB recording and \nreporting system needs to include a minimal set of data elements. Although paper-based systems have \nbeen used to collect such data, it is now becoming increasingly feasible to collect data electronically, \nand this should be the standard aspired to for monitoring TB screening activities. The following \nstrategies can be used to collect the necessary data:\n•\t maintain a log of the number of people screened in each risk group. A special register with \nindividual-level information for each person",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the minimum recording and reporting needed for TB screening indicators, preferably electronic, including logs of people screened and registers of people with presumptive TB. It recommends adding fields to laboratory and treatment registers showing whether patients were found through screening and their risk group.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-028",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Programmatic evaluations",
      "pageStart": 50,
      "pageEnd": 51,
      "target": "../sections/sec-028-43-programmatic-evaluations.md",
      "narrative": null,
      "content": "A successful screening programme may lead to a diminishing yield, at least if the risk group is a fixed \npopulation. Over time, changes in the background burden of TB, as well as changes in the profile \nof TB patients in the community (e.g. a trend towards fewer patients with symptomatic TB) can lead \nto a reduction in the yield from screening, an increase in the NNS, a reduction in cost–effectiveness \nand a change in the ratio of benefits to harms. Trends in all of these indicators need to be monitored, \nand the prioritization of risk groups, choice of screening approach and screening interva",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that screening yield may fall over time, so indicators and choices of risk groups, approaches and intervals should be reassessed, with stopping criteria set in advance. It notes that unexpected indicator results may call for special assessments of barriers to screening.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-029",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Initial calibration for computer-aided detection technologies",
      "pageStart": 51,
      "pageEnd": 53,
      "target": "../sections/sec-029-44-initial-calibration-for-computer-aided-detect.md",
      "narrative": null,
      "content": "technologies\nWhen CAD is implemented, local calibration is advised to customize the score thresholds to the \nrequirements of the programme (see the operational handbook for more details about how this can \nbe done) (7). After this initial calibration, ongoing monitoring and analysis of CAD performance should \nbe carried out to assess the correlation with human readers’ interpretations and with bacteriological \nconfirmation, and with the proportion of images read as abnormal and requiring further investigation.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Advises local calibration of computer-aided detection score thresholds and ongoing monitoring of its performance against human readers and bacteriological results.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-030",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Research gaps",
      "pageStart": 53,
      "pageEnd": 53,
      "target": "../sections/sec-030-5-research-gaps.md",
      "narrative": null,
      "content": "5. Research gaps",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A section heading for the chapter on research gaps.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-031",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Screening for TB in targeted populations",
      "pageStart": 53,
      "pageEnd": 54,
      "target": "../sections/sec-031-51-screening-for-tb-in-targeted-populations.md",
      "narrative": null,
      "content": "5.1.1 The general population and high-risk groups\nWell-designed trials and rigorous quasi-experimental studies in different settings are required to \ninvestigate the effects of population-wide systematic screening for TB on individual-level outcomes \n(diagnostic delay, treatment outcomes, costs to patients, social consequences) and population-\nlevel outcomes (TB prevalence, incidence, transmission), as well as to guide implementation choices \n(including the method of delivery, screening algorithms, the duration of screening intervals and \nfrequency of screening, and the mode of delivering the",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Identifies research needs on population-wide and targeted TB screening, including trials of effects on individual and population outcomes, implementation choices and long-term cost-effectiveness. It calls for carefully designed observational studies of community screening and more evidence on screening frequency and outcomes for high-risk children.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-032",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Tools for screening for TB",
      "pageStart": 54,
      "pageEnd": 55,
      "target": "../sections/sec-032-52-tools-for-screening-for-tb.md",
      "narrative": null,
      "content": "5.2.1 Computer-aided detection\nFurther evidence is needed about the performance of CAD software stratified according to the \ncharacteristics of the individual being evaluated (e.g. by smear status, HIV status, age cohort, history \nof TB, smoking status, sex) to allow for better setting-specific and patient-specific calibration of \nCAD programmes.\nMore research on users’ perspectives is needed about CAD technologies in TB screening and triage, \nincluding their perceived acceptability to patients, providers and other stakeholders.\nThe development and evaluation of CAD programmes for automated de",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists research gaps on screening tools, including CAD performance across patient groups, user acceptability and CAD for children. It also calls for studies of higher C-reactive protein cut-offs in people with HIV and of complete screening and diagnostic algorithms against patient outcomes.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-033",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Operational research",
      "pageStart": 55,
      "pageEnd": 57,
      "target": "../sections/sec-033-53-operational-research.md",
      "narrative": null,
      "content": "Standard monitoring and evaluation procedures may be complemented by operational research \naimed at improving the performance of screening in the local setting as well as research aimed at \nimproving the global evidence base for screening. Topics that may be explored include:\n•\t assessing the accuracy and performance of different algorithms for screening and diagnosis;\n•\t identifying operational challenges and solutions;\n•\t identifying the best ways to improve acceptability and minimize the harms of screening;\n•\t establishing the effectiveness and cost–effectiveness of screening in different r",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Suggests operational research topics for TB screening programmes, such as algorithm performance, acceptability, cost-effectiveness and local CAD calibration, and calls for larger randomized trials.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-034",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 57,
      "pageEnd": 62,
      "target": "../sections/sec-034-6-references.md",
      "narrative": null,
      "content": "1.\t Global tuberculosis report 2020. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/\nbitstream/handle/10665/336069/9789240013131-eng.pdf, accessed 19 February 2021).\n2.\t Uplekar M, Weil D, Lönnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO’s new End TB Strategy. Lancet. \n2015;385:1799–801. doi:10.1016/s0140–6736(15)60570–0.\n3.\t The End TB Strategy [website]. Geneva: World Health Organization; 2021 (http://www.who.int/tb/strategy/\nen/, accessed 19 February 2021).\n4.\t Political declaration of the UN General Assembly High-Level Meeting on the Fight Against Tuberculosis.",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The reference list for the WHO TB screening guidelines, citing WHO reports, handbooks and policies and research studies on TB screening and diagnosis.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-035",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Summary of changes to existing recommendations",
      "pageStart": 62,
      "pageEnd": 63,
      "target": "../sections/sec-035-summary-of-changes-to-existing-recommendations.md",
      "narrative": null,
      "content": "2013 Recommendation\n2021 Recommendation\nHousehold contacts and other close contacts \nshould be systematically screened for active \nTB (strong recommendation, very low-\nquality evidence).\nHousehold contacts and other close \ncontacts of individuals with TB should be \nsystematically screened for TB disease \n(strong recommendation, moderate certainty \nof evidence).\nPeople living with HIV should be systematically \nscreened for active TB at each visit to a health \nfacility (strong recommendation, very low-\nquality evidence).\nPeople living with HIV should be systematically \nscreened for TB disease at",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A table comparing 2013 and 2021 TB screening recommendations for groups such as household contacts, people with HIV, silica-exposed workers, prisoners and the general population in high-prevalence areas. It shows updated wording and evidence ratings, with prison screening strengthened from a conditional to a strong recommendation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/prose-sec-036",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Supplementary Table",
      "pageStart": 63,
      "pageEnd": 68,
      "target": "../sections/sec-036-supplementary-table.md",
      "narrative": null,
      "content": "2013 Recommendation\n2021 Recommendation\nSystematic screening for active TB may be \nconsidered also for other subpopulations that \nhave very poor access to health care, such \nas people living in urban slums, homeless \npeople, people living in remote areas with \npoor access to health care, and other \nvulnerable or marginalized groups including \nsome indigenous populations, migrants and \nrefugees (conditional recommendation, very \nlow-quality evidence).\nSystematic screening for TB disease may be \nconducted for subpopulations with structural \nrisk factors for TB. These include urban \npoor communit",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A supplementary table continuing the comparison of 2013 and 2021 recommendations, for marginalized groups with poor access to care and for people living with HIV, followed by WHO Global Tuberculosis Programme contact details.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-340255/blocks/figure-img-p068-1",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 68,
      "pageEnd": 68,
      "target": "../images/img-p068-1.webp",
      "narrative": "draft",
      "content": "ISBN barcode for 9789240022676.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    }
  ]
}
